» Articles » PMID: 13712680

On the Size of the Toxic Particle Passing the Intestinal Barrier in Botulism

Overview
Journal J Exp Med
Date 1960 Jun 1
PMID 13712680
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

On the basis of toxicity assays using partition centrifugation cells it was established that the sedimentation coefficient of type A botulinum toxin appearing in the lymph of orally poisoned rats was 7.9 x 10(-18) cm. per dyne sec. with 95 per cent confidence limits of 4.4 to 11.4 x 10(-13) cm. per dyne sec. This is a significantly lower value than that obtained for crystalline toxin but is well within the range of size for proteins. Exposure of crystalline toxin for 2 hours to digestive processes in a section of the duodenum of living rats did not significantly reduce the sedimentation coefficient of the toxin. The S(20) of crystalline toxin employed in the present study ranged between 12 and 21 with a mean value of 17.9. While it was observed that both botulinum toxin and albumin sedimented from lymph in glycerol gradient tubes to essentially the same level no evidence was developed to indicate association between toxin in lymph and serum albumin. The electrophoretic mobility of toxin in lymph is like that of crystalline toxin and not albumin. Dialysis of toxic lymph against serum albumin does not result in the appearance of toxin in the dialysate.

Citing Articles

Confirmation of botulism diagnosis in Australian bird samples by ELISA and RT rtPCR.

Masters A, Palmer D J Vet Diagn Invest. 2021; 33(4):684-694.

PMID: 33955287 PMC: 8229820. DOI: 10.1177/10406387211014486.


The role of the single interchains disulfide bond in tetanus and botulinum neurotoxins and the development of antitetanus and antibotulism drugs.

Rossetto O, Pirazzini M, Lista F, Montecucco C Cell Microbiol. 2019; 21(11):e13037.

PMID: 31050145 PMC: 6899712. DOI: 10.1111/cmi.13037.


Mucosal vaccine development for botulinum intoxication.

Fujihashi K, Staats H, Kozaki S, Pascual D Expert Rev Vaccines. 2007; 6(1):35-45.

PMID: 17280477 PMC: 9808531. DOI: 10.1586/14760584.6.1.35.


IMMUNOLOGICAL ASPECTS OF AIRBORNE INFECTION: SOME GENERAL CONSIDERATIONS OF RESPONSE TO INHALATION OF TOXINS.

Lamanna C Bacteriol Rev. 1961; 25(3):323-30.

PMID: 16350175 PMC: 441111. DOI: 10.1128/br.25.3.323-330.1961.


Glycosphingolipids-sweets for botulinum neurotoxin.

Yowler B, Schengrund C Glycoconj J. 2004; 21(6):287-93.

PMID: 15514477 DOI: 10.1023/B:GLYC.0000046271.64647.fd.


References
1.
Lowenthal J, Lamanna C . Characterization of botulinal hemagglutination. Am J Hyg. 1953; 57(1):46-59. DOI: 10.1093/oxfordjournals.aje.a119562. View

2.
Wagman J . Isolation and sedimentation study of low molecular weight forms of type A Botulins toxin. Arch Biochem Biophys. 1954; 50(1):104-12. DOI: 10.1016/0003-9861(54)90013-2. View

3.
HECKLY R . Electrolytically controlled device for dispensing liquids. Science. 1958; 127(3292):233-4. DOI: 10.1126/science.127.3292.233. View

4.
May A, WHALER B . The absorption of Clostridium botulinum type A toxin from the alimentary canal. Br J Exp Pathol. 1958; 39(3):307-16. PMC: 2082215. View

5.
HECKLY R . Fractionation by free electrophoresis. Biochim Biophys Acta. 1960; 38:370-2. DOI: 10.1016/0006-3002(60)91264-6. View